-

Mexedia Continues Its Industrial Development Path and Strengthens the Tools Supporting Its Growth

ROME--(BUSINESS WIRE)--Regulatory News:

Mexedia S.p.A. continues its industrial development path, in a context where execution capability, operational discipline and decision-making speed are increasingly relevant.

Share

Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) continues its industrial development path, in a context where execution capability, operational discipline and decision-making speed are increasingly relevant.

Following the resolutions adopted by the Shareholders’ Meeting held on March 13, 2026, the Company now benefits from a broader set of tools supporting its growth trajectory. These tools, already described in the press release issued on March 18, 2026, enhance the Group’s ability to evaluate and structure, over time, initiatives consistent with its industrial strategy, enabling a more flexible approach in managing opportunities and in the evolution of its operational perimeter.

In this context, Mexedia intends to continue its development with a progressive and selective approach, focusing on strengthening its existing activities and on its ability to identify opportunities aligned with its industrial model, while maintaining a balance between growth and operational sustainability.

At the same time, the Company continues to strengthen its operational structure, with targeted actions aimed at optimizing processes, improving efficiency and developing internal capabilities, which are considered essential to support the scalability of its activities and ensure continuity of results. During the first months of the year, Mexedia has also consolidated relationships with clients and partners, further developing its existing activities with a focus on service quality and operational stability.

Paolo Bona, CEO of Mexedia, commented: “The resolutions adopted by the Shareholders’ Meeting define a broader operational perimeter within which we can move in the next phase of our development. Our objective is to continue growing in line with our industrial model, maintaining discipline and selectively leveraging opportunities that can strengthen the Group’s positioning over time.”

About Mexedia

Mexedia S.p.A. Società Benefit is a company listed on Euronext Growth Paris, active in technological services and communication solutions between businesses and customers. The Group operates internationally, collaborating with clients and partners across various markets and supporting the evolution of business models through scalable and integrated solutions.

Mexedia develops and manages services that enable communication and interaction between brands and end users, with a focus on operational quality, service continuity and process efficiency.

As a Società Benefit, Mexedia integrates social and environmental sustainability objectives into its business model, promoting initiatives and activities consistent with a responsible approach to development and with the aim of generating a positive impact in the context in which it operates.

Information pursuant to the Market Abuse Regulation (MAR)

This press release is issued pursuant to Article 17 of Regulation (EU) No. 596/2014 (Market Abuse Regulation). This press release is for information purposes only and does not contain inside information within the meaning of applicable regulations.

Contacts

Mexedia S.p.A. Società Benefit – Investor Relations
Vincenzo La Barbera
investor.relations@mexedia.com
+39 351 8447229

Mexedia S.p.A.

BOURSE:ALMEX
Details
Headquarters: Rome, Italy
CEO: Paolo Bona
Employees: 10
Organization: PUB

Release Versions

Contacts

Mexedia S.p.A. Società Benefit – Investor Relations
Vincenzo La Barbera
investor.relations@mexedia.com
+39 351 8447229

More News From Mexedia S.p.A.

Mexedia S.p.A. Società Benefit: Management Discipline and Operational Approach in the Group’s Evolution Path

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued in 2025, confirms its commitment to strengthening management discipline and adopting an operational approach focused on efficiency, quality of activities and long-term sustainability. During the last financial year, the Group implemented a set of actions aimed at streamlining its operating perimeter and progressi...

Mexedia S.p.A. Società Benefit: Approval of the Draft Statutory and Consolidated Financial Statements as of December 31, 2025

ROME--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), meeting today, approved the draft statutory financial statements and the consolidated financial statements for the year ended December 31, 2025. ✓ Consolidated revenues at €118.1 million (+62.0% compared to €72.9 million in 2024) ✓ Gross margin at €10.2 million (+38.2% compared to €7.4 million in 2024) ✓ EBITDA at €-1.2 million (improving from €-23...

Mexedia Among the Leading Teams at Race for the Cure 2026

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819) is pleased to announce that, as part of its participation in the Race for the Cure 2026, the Mexedia & Friends team currently ranks fifth among the teams with the highest number of registered participants. This result continues to grow day by day and represents much more than a numerical milestone: an increasing number of people are choosing to join Mexedia & Friends...
Back to Newsroom